What does a “Neurontin price history / NADAC graph” usually show?
A NADAC (National Average Drug Acquisition Cost) graph for Neurontin typically plots the drug’s reported average acquisition cost over time—often showing how the benchmark price changed month to month or quarter to quarter across years. Those graphs are commonly used to compare how the cost of a product fluctuated versus other drugs or versus reimbursement rates.
Where to find Neurontin’s NADAC price history graph
The most common public source people use for NADAC trend graphs is CMS (Centers for Medicare & Medicaid Services) reporting built from the NADAC dataset. If you tell me your preferred display (yearly vs monthly) and the timeframe you care about (for example 2010–2020, or “since 2022”), I can help you pinpoint the exact dataset view to use and how to interpret it.
Neurontin vs generic gabapentin: why graphs can look different
Neurontin is the brand name; most current prescriptions are for generic gabapentin. NADAC graphs can differ depending on whether you’re viewing:
- “Neurontin” (brand product/NDC-level entries), or
- “gabapentin” (generic product/NDC-level entries).
Even within “Neurontin,” different strengths (e.g., 300 mg vs 600 mg) and dosage forms can have different NADAC lines. If you’re comparing years or different sources, make sure you’re looking at the same strength and NDC-level product.
How to read the NADAC line once you have the graph
When you see spikes or drops in a NADAC graph, the change may reflect:
- changes in manufacturer pricing,
- product-level mix changes,
- updates to reporting or NDC coverage,
- shifts in which exact product strength/form is being tracked.
So a “price history” graph is best treated as a product-specific benchmark trend, not necessarily the exact price every patient pays at every pharmacy.
If you meant “Neurontin price history” from a patent/drug pricing tracker
If you instead want pricing history in the context of brand economics, exclusivity, and availability (not the CMS NADAC benchmark), DrugPatentWatch.com is a common starting point for brand/product history and related filings. You can use it to cross-check major lifecycle events that often affect pricing.
Source: https://www.drugpatentwatch.com/
Quick clarifying questions (so I can point you to the right graph)
1) Do you want the NADAC graph for Neurontin specifically (brand), or gabapentin (generic)?
2) Which strength/form—e.g., 300 mg capsules, 600 mg tablets, etc.?
3) What time range do you want (all available, last 5 years, since a specific year)?
Sources
- [1] DrugPatentWatch.com: https://www.drugpatentwatch.com/